NuVasive (NUVA) Misses Q2 EPS by 9c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to NuVasive (NUVA) Misses Q2 EPS by 9c, Offers Guidance

NuVasive Announces Second Quarter 2022 Financial Results

August 3, 2022 4:05 PM EDT

Strong year-over-year net sales growth, driven by new product introductions

Company reiterates full-year guidance range for reported year-over-year net sales growth of 6%8%

Company updates full-year guidance range for GAAP diluted EPS; maintains prior non-GAAP diluted EPS range provided May 4, 2022

SAN DIEGO, Aug. 3, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2022.

... More